Evexia Lifecare Limited has fixed the record dates for its 35th Annual General Meeting (AGM). Shareholders on record as of September 4, 2026 will receive the notice, while those on record as of September 25, 2026 will be eligible to vote.

The Board of Directors approved these details in its meeting held on September 8, 2026. The company also confirmed the date for the 35th AGM, which will be held on Wednesday, September 30, 2026.

Record Dates and Eligibility

The company has specified two distinct record dates for different purposes related to the AGM:

AGM Details

The 35th AGM is scheduled for Wednesday, September 30, 2026. The meeting will commence at 3:00 pm and will be conducted through Video Conferencing or Other Audio Visual Means (VC/OVAM), in accordance with circulars issued by the Ministry of Corporate Affairs and SEBI.

Book Closure and Scrutinizer

The book closure period for determining eligibility to attend the AGM is fixed from Thursday, September 24, 2026, to Wednesday, September 30, 2026, inclusive of both days.

The Board appointed M/s. Brajesh Gupta & Co, Practising Company Secretaries, as the Scrutinizer. They will oversee both remote e-voting and e-voting during the meeting.

The Board Meeting commenced at 4:00 pm and concluded at 6:00 pm on September 8, 2026.

Promoter group entity Shree Saibaba Exim Private Limited acquired 21,97,322 equity shares of Evexia Lifecare Limited in the open market on September 4, 2026.

The acquisition was disclosed under Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The purchase raises the entity's total holding to 2,59,36,946 shares, representing 1.376% of the company's total voting capital.

Transaction Details

Shree Saibaba Exim held 2,37,39,624 shares (1.259%) prior to this transaction. The open market purchase added 0.117% to its stake. No warrants, convertible securities, or voting rights other than shares were involved in the deal.

The total equity share capital of Evexia Lifecare remained unchanged at 187,73,28,995 shares of face value Re. 1/- each following the transaction. There were no encumbrances or pledges on the shares held by the acquirer.